Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080211 | SCV000112106 | benign | not specified | 2016-10-05 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000080211 | SCV000193473 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000080211 | SCV000309630 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Laboratory for Molecular Medicine, |
RCV000080211 | SCV000539485 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
ARUP Laboratories, |
RCV000999790 | SCV000604079 | benign | Kabuki syndrome 1 | 2018-08-23 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000712311 | SCV000842776 | benign | not provided | 2018-05-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001514086 | SCV001721837 | benign | Kabuki syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000712311 | SCV001940582 | benign | not provided | 2020-05-12 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000999790 | SCV001981143 | benign | Kabuki syndrome 1 | 2021-08-19 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000080211 | SCV004233180 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 64% of patients studied by a panel of primary immunodeficiencies. Number of patients: 61. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV000712311 | SCV005235754 | benign | not provided | criteria provided, single submitter | not provided |